PTC Therapeutics, Inc. (PTCT)
74.22
+0.75
(+1.02%)
USD |
NASDAQ |
Dec 10, 13:36
PTC Therapeutics EPS Diluted (Quarterly): 0.195 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | -0.184 |
| Pyxis Oncology, Inc. | -0.3517 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.90M |
| Revenue (Quarterly) | 211.01M |
| Total Expenses (Quarterly) | 195.11M |
| Enterprise Value | 4.621B |
| Gross Profit Margin (Quarterly) | 88.95% |
| Profit Margin (Quarterly) | 7.53% |
| Earnings Yield | 11.53% |
| Operating Earnings Yield | 15.11% |
| Normalized Earnings Yield | 13.32 |